Success Metrics

Clinical Success Rate
66.7%

Based on 4 completed trials

Completion Rate
67%(4/6)
Active Trials
1(10%)
Results Posted
100%(4 trials)
Terminated
2(20%)

Phase Distribution

Ph phase_1
3
30%
Ph phase_2
5
50%
Ph not_applicable
2
20%

Phase Distribution

3

Early Stage

5

Mid Stage

0

Late Stage

Phase Distribution10 total trials
Phase 1Safety & dosage
3(30.0%)
Phase 2Efficacy & side effects
5(50.0%)
N/ANon-phased studies
2(20.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

50.0%

4 of 8 finished

Non-Completion Rate

50.0%

4 ended early

Currently Active

1

trials recruiting

Total Trials

10

all time

Status Distribution
Active(1)
Completed(4)
Terminated(4)
Other(1)

Detailed Status

Completed4
Terminated2
Withdrawn2
Recruiting1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
10
Active
1
Success Rate
66.7%
Most Advanced
Phase 2

Trials by Phase

Phase 13 (30.0%)
Phase 25 (50.0%)
N/A2 (20.0%)

Trials by Status

recruiting110%
terminated220%
unknown110%
withdrawn220%
completed440%

Recent Activity

1 active trials
Showing 5 of 10
recruitingnot_applicable

Electrochemotherapy-Induced Changes in Tumor Microenvironment in Cutaneous Melanoma

NCT07404605
completednot_applicable

Electrochemotherapy for the Inoperable Vulva Carcinoma

NCT03142061
completedphase_1

Treatment of Primary Liver Tumors With Electrochemotherapy (ECT)

NCT02291133
completedphase_2

Treatment of Liver Metastases With Electrochemotherapy (ECTJ) Phase II

NCT02352259
completedphase_1

Treatment of Liver Metastases With Electrochemotherapy

NCT01264952
View all 10 trials

Clinical Trials (10)

Showing 10 of 10 trials
NCT07404605Not Applicable

Electrochemotherapy-Induced Changes in Tumor Microenvironment in Cutaneous Melanoma

Recruiting
NCT03142061Not Applicable

Electrochemotherapy for the Inoperable Vulva Carcinoma

Completed
NCT02291133Phase 1

Treatment of Primary Liver Tumors With Electrochemotherapy (ECT)

Completed
NCT02352259Phase 2

Treatment of Liver Metastases With Electrochemotherapy (ECTJ) Phase II

Completed
NCT01264952Phase 1

Treatment of Liver Metastases With Electrochemotherapy

Completed
NCT02549742Phase 2

Electrochemotherapy on Head and Neck Cancer

Unknown
NCT02709811Phase 1

Safety and Feasibility of Electrochemotherapy in Unresectable Colorectal Adenocarninoma Liver Metastases

Terminated
NCT01479946Phase 2

Electrochemotherapy For The Treatment Of Breast Cancer That Has Spread to the Skin

Withdrawn
NCT00744653Phase 2

Electrochemotherapy for Chest Wall Recurrence af Breast Cancer: Present Challenges and Future Prospects.

Terminated
NCT00918593Phase 2

Palliative Treatment of Ulcerated Cutaneous Metastases: Trial Between Electrochemotherapy and Radiotherapy

Withdrawn

All 10 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
10